Cambridge Investment Research Advisors
VSTM icon

Cambridge Investment Research Advisors’s Verastem VSTM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-871
Closed -$4K – 3263
2022
Q4 		$4K Hold
871
– – ﹤0.01% 3090
2022
Q3 		$9K Sell
871
-4,004
-82% -$55.9K ﹤0.01% 3025
2022
Q2 		$68K Sell
4,875
-195
-4% -$3.11K ﹤0.01% 2912
2022
Q1 		$86K Sell
5,070
-161
-3% -$2.77K ﹤0.01% 3035
2021
Q4 		$129K Hold
5,231
– – ﹤0.01% 2995
2021
Q3 		$193K Buy
5,231
+292
+6% +$10.7K ﹤0.01% 2824
2021
Q2 		$241K Sell
4,939
-529
-10% -$22.1K ﹤0.01% 2658
2021
Q1 		$162K Buy
5,468
+683
+14% +$19.1K ﹤0.01% 2689
2020
Q4 		$122K Sell
4,785
-416
-8% -$8.36K ﹤0.01% 2573
2020
Q3 		$76K Sell
5,201
-265
-5% -$4.39K ﹤0.01% 2423
2020
Q2 		$113K Buy
5,466
+356
+7% +$9.42K ﹤0.01% 2308
2020
Q1 		$162K Buy
5,110
+1,025
+25% +$25.7K ﹤0.01% 1997
2019
Q4 		$66K Buy
4,085
+84
+2% +$1.21K ﹤0.01% 2341
2019
Q3 		$58K Buy
4,001
+500
+14% +$8.12K ﹤0.01% 2268
2019
Q2 		$63K Buy
3,501
+254
+8% +$5.75K ﹤0.01% 2135
2019
Q1 		$115K Buy
+3,247
New +$128K ﹤0.01% 2172

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Cambridge Investment Research Advisors's VSTM Position: Q1 2023 in Review

Cambridge Investment Research Advisors sold out of Verastem (VSTM) in Q1 2023, closing a stake of 871 shares — an estimated $4K sold.

Cambridge Investment Research Advisors first reported a position in VSTM in Q1 2019 and held it in 16 quarters. The position peaked at $241K in Q2 2021. 80 funds tracked by Wall St. Rank hold VSTM as of Q1 2023.

  • Cambridge Investment Research Advisors reported no remaining Verastem position as of Q1 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 871 Verastem shares in Q1 2023, an estimated $4K.
  • Cambridge Investment Research Advisors first reported a position in Verastem in Q1 2019 and held it in 16 quarters.
  • Cambridge Investment Research Advisors's Verastem position peaked at $241K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Verastem as of Q1 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.